ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BioLineRx Announces Initiation of Triple Combination Arm of Pancreatic Cancer Study
December 12, 2018BioLineRx announced the initiation of the triple combination arm of the Phase 2a COMBAT/KEYNOTE-202 study in patients with metastatic pancreatic cancer (PDAC) under its immuno-oncology..... -
BioLineRx Reports Results of Phase 2 Study for BL-8040 Monotherapy
May 18, 2018Mobilization of hematopoietic stem and progenitor cells (HSPCs) for the purpose of donor (allogeneic) transplantation after high-dose chemotherapy is currently performed using a 4-5 day treatment cycle with G-CSF and a 1-2 day apheresis procedure. -
BioLineRx Announces Partial Monotherapy Results From Phase IIa COMBAT Study in Pancreatic Cancer
January 18, 2018Partial results of the monotherapy portion of Phase 2a COMBAT study of BL-8040 showed that BL-8040 increased the tumor invasion of tumor and immune infiltrating T cells into patients with metastatic pancreatic cancer. -
BioLineRx Announces Initiation Stem-Cell Mobilization for Autologous Transplantation Trial
December 26, 2017BioLineRx Announces Launch of Phase III GENESIS Clinical Trial，，， -
BioLineRx Announces Submission of Phase 3 Registrational Study for BL-8040
August 23, 2017BioLineRx announced the filing of regulatory submissions required to commence a randomized, controlled Phase 3 registrational trial of BL-8040 for the mobilization of hematopoietic stem cells for autologous transplantation in patients with multiple myelom
Pharma Sources Insight January 2025
